NKTR logo

Nektar Therapeutics (NKTR) Operating Profit

Annual Operating Profit:

-$129.92M+$5.31M(+3.92%)
December 31, 2024

Summary

  • As of today, NKTR annual operating income is -$129.92 million, with the most recent change of +$5.31 million (+3.92%) on December 31, 2024.
  • During the last 3 years, NKTR annual operating profit has risen by +$316.19 million (+70.88%).
  • NKTR annual operating profit is now -118.89% below its all-time high of $687.93 million, reached on December 31, 2018.

Performance

NKTR Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

Quarterly Operating Profit:

-$35.78M+$8.58M(+19.35%)
June 30, 2025

Summary

  • As of today, NKTR quarterly operating income is -$35.78 million, with the most recent change of +$8.58 million (+19.35%) on June 30, 2025.
  • Over the past year, NKTR quarterly operating profit has increased by +$702.00 thousand (+1.92%).
  • NKTR quarterly operating profit is now -103.68% below its all-time high of $973.60 million, reached on June 30, 2018.

Performance

NKTR Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

TTM Operating Profit:

-$139.13M+$702.00K(+0.50%)
June 30, 2025

Summary

  • As of today, NKTR TTM operating income is -$139.13 million, with the most recent change of +$702.00 thousand (+0.50%) on June 30, 2025.
  • Over the past year, NKTR TTM operating profit has dropped by -$4.03 million (-2.98%).
  • NKTR TTM operating profit is now -114.67% below its all-time high of $948.29 million, reached on June 30, 2018.

Performance

NKTR TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

NKTR Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+3.9%+1.9%-3.0%
3Y3 Years+70.9%+23.5%+64.2%
5Y5 Years+70.5%+54.0%+63.3%

NKTR Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+70.9%-45.0%+19.4%-7.1%+55.4%
5Y5-Yearat high+70.9%-45.0%+68.9%-7.1%+69.2%
All-TimeAll-Time-118.9%+70.9%-103.7%+70.3%-114.7%+69.2%

NKTR Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$35.78M(+19.3%)
-$139.13M(+0.5%)
Mar 2025
-
-$44.37M(-79.8%)
-$139.83M(-7.6%)
Dec 2024
-$129.92M(+3.9%)
-$24.68M(+28.0%)
-$129.92M(+4.4%)
Sep 2024
-
-$34.30M(+6.0%)
-$135.90M(-0.6%)
Jun 2024
-
-$36.48M(-5.9%)
-$135.10M(-1.8%)
Mar 2024
-
-$34.45M(-12.4%)
-$132.66M(+1.9%)
Dec 2023
-$135.22M(+43.7%)
-$30.66M(+8.5%)
-$135.22M(+7.0%)
Sep 2023
-
-$33.50M(+1.6%)
-$145.45M(+2.7%)
Jun 2023
-
-$34.05M(+8.0%)
-$149.42M(+7.9%)
Mar 2023
-
-$37.02M(+9.5%)
-$162.17M(+32.5%)
Dec 2022
-$240.24M(+46.1%)
-$40.89M(-9.1%)
-$240.24M(+23.1%)
Sep 2022
-
-$37.47M(+19.9%)
-$312.26M(+19.6%)
Jun 2022
-
-$46.79M(+59.3%)
-$388.38M(+14.0%)
Mar 2022
-
-$115.08M(-1.9%)
-$451.80M(-1.3%)
Dec 2021
-$446.10M(-17.4%)
-$112.91M(+0.6%)
-$446.10M(-0.5%)
Sep 2021
-
-$113.60M(-3.1%)
-$443.91M(-2.4%)
Jun 2021
-
-$110.20M(-0.7%)
-$433.37M(-8.1%)
Mar 2021
-
-$109.39M(+1.2%)
-$400.87M(-5.5%)
Dec 2020
-$379.92M(+13.7%)
-$110.72M(-7.4%)
-$379.92M(-0.3%)
Sep 2020
-
-$103.05M(-32.6%)
-$378.84M(-1.2%)
Jun 2020
-
-$77.71M(+12.1%)
-$374.53M(+8.2%)
Mar 2020
-
-$88.44M(+19.3%)
-$407.79M(+7.3%)
Dec 2019
-$440.04M(-164.0%)
-$109.64M(-11.0%)
-$440.04M(-2.2%)
Sep 2019
-
-$98.74M(+11.0%)
-$430.69M(-0.0%)
Jun 2019
-
-$110.97M(+8.1%)
-$430.59M(-165.8%)
Mar 2019
-
-$120.69M(-20.3%)
$653.98M(-4.9%)
Dec 2018
$687.93M(+1675.6%)
-$100.30M(-1.7%)
$687.93M(-11.8%)
Sep 2018
-
-$98.63M(-110.1%)
$780.17M(-17.7%)
Jun 2018
-
$973.60M(+1222.4%)
$948.29M(+1348.4%)
Mar 2018
-
-$86.74M(-977.1%)
-$75.96M(-74.0%)
Dec 2017
-$43.66M(+61.3%)
-$8.05M(-111.6%)
-$43.66M(+35.6%)
Sep 2017
-
$69.48M(+237.2%)
-$67.75M(+60.2%)
Jun 2017
-
-$50.66M(+6.9%)
-$170.14M(-7.8%)
Mar 2017
-
-$54.44M(-69.4%)
-$157.81M(-39.8%)
Dec 2016
-$112.86M(-284.2%)
-$32.14M(+2.3%)
-$112.85M(-2.5%)
Sep 2016
-
-$32.90M(+14.2%)
-$110.07M(-43.4%)
Jun 2016
-
-$38.33M(-304.1%)
-$76.75M(+6.3%)
Mar 2016
-
-$9.48M(+67.7%)
-$81.90M(-178.8%)
Dec 2015
-$29.37M(-78.2%)
-$29.36M(-7108.1%)
-$29.37M(+21.7%)
Sep 2015
-
$419.00K(+101.0%)
-$37.49M(-188.4%)
Jun 2015
-
-$43.47M(-201.0%)
$42.41M(-32.6%)
Mar 2015
-
$43.04M(+214.8%)
$62.96M(+481.9%)
Dec 2014
-$16.48M(+86.3%)
-$37.49M(-146.7%)
-$16.48M(-10.7%)
Sep 2014
-
$80.32M(+450.5%)
-$14.89M(+85.4%)
Jun 2014
-
-$22.92M(+37.0%)
-$101.74M(+8.7%)
Mar 2014
-
-$36.40M(-1.4%)
-$111.43M(+7.2%)
Dec 2013
-$120.13M(+13.9%)
-$35.89M(-450.1%)
-$120.13M(+5.9%)
Sep 2013
-
-$6.53M(+80.0%)
-$127.61M(+17.1%)
Jun 2013
-
-$32.60M(+27.7%)
-$153.99M(-3.8%)
Mar 2013
-
-$45.10M(-4.0%)
-$148.37M(-6.3%)
Dec 2012
-$139.53M(-12.6%)
-$43.38M(-31.9%)
-$139.53M(-6.8%)
Sep 2012
-
-$32.90M(-21.9%)
-$130.61M(-9.7%)
Jun 2012
-
-$26.99M(+25.6%)
-$119.05M(+5.8%)
Mar 2012
-
-$36.26M(-5.2%)
-$126.33M(-1.9%)
Dec 2011
-$123.94M(-690.5%)
-$34.47M(-61.5%)
-$123.94M(-27.2%)
Sep 2011
-
-$21.34M(+37.7%)
-$97.43M(-18.4%)
Jun 2011
-
-$34.26M(-1.2%)
-$82.32M(-78.2%)
Mar 2011
-
-$33.87M(-325.3%)
-$46.19M(-194.6%)
Dec 2010
-$15.68M(+83.5%)
-$7.96M(-27.9%)
-$15.68M(-18.7%)
Sep 2010
-
-$6.22M(-433.4%)
-$13.21M(+63.1%)
Jun 2010
-
$1.87M(+155.6%)
-$35.84M(+47.4%)
Mar 2010
-
-$3.36M(+38.9%)
-$68.19M(+28.3%)
Dec 2009
-$95.13M
-$5.50M(+81.0%)
-$95.13M(-55.9%)
DateAnnualQuarterlyTTM
Sep 2009
-
-$28.86M(+5.3%)
-$61.02M(+8.5%)
Jun 2009
-
-$30.48M(-0.6%)
-$66.72M(+4.1%)
Mar 2009
-
-$30.30M(-205.9%)
-$69.60M(+14.3%)
Dec 2008
-$81.19M(-124.6%)
$28.61M(+182.8%)
-$81.19M(-12.1%)
Sep 2008
-
-$34.56M(-3.6%)
-$72.43M(-26.1%)
Jun 2008
-
-$33.36M(+20.4%)
-$57.44M(-10.3%)
Mar 2008
-
-$41.89M(-212.1%)
-$52.07M(-44.0%)
Dec 2007
-$36.15M(+77.3%)
$37.38M(+291.0%)
-$36.15M(+68.2%)
Sep 2007
-
-$19.57M(+30.1%)
-$113.69M(+2.7%)
Jun 2007
-
-$27.99M(-7.8%)
-$116.80M(+23.2%)
Mar 2007
-
-$25.97M(+35.3%)
-$152.03M(+4.5%)
Dec 2006
-$159.23M(+8.9%)
-$40.16M(-77.1%)
-$159.23M(+27.6%)
Sep 2006
-
-$22.68M(+64.1%)
-$219.93M(+0.3%)
Jun 2006
-
-$63.21M(-90.5%)
-$220.62M(-20.0%)
Mar 2006
-
-$33.17M(+67.1%)
-$183.86M(-5.2%)
Dec 2005
-$174.77M(-136.4%)
-$100.86M(-331.7%)
-$174.77M(-89.3%)
Sep 2005
-
-$23.37M(+11.7%)
-$92.31M(-5.2%)
Jun 2005
-
-$26.45M(-9.8%)
-$87.77M(-6.5%)
Mar 2005
-
-$24.09M(-30.9%)
-$82.44M(-11.2%)
Dec 2004
-$73.94M(-11.7%)
-$18.40M(+2.3%)
-$74.15M(+2.0%)
Sep 2004
-
-$18.83M(+10.8%)
-$75.66M(-6.6%)
Jun 2004
-
-$21.12M(-33.6%)
-$70.97M(-10.1%)
Mar 2004
-
-$15.81M(+20.6%)
-$64.45M(+2.6%)
Dec 2003
-$66.19M(+33.9%)
-$19.91M(-40.9%)
-$66.19M(+12.4%)
Sep 2003
-
-$14.13M(+3.2%)
-$75.52M(+12.2%)
Jun 2003
-
-$14.60M(+16.7%)
-$85.97M(+8.6%)
Mar 2003
-
-$17.54M(+40.0%)
-$94.04M(+6.0%)
Dec 2002
-$100.08M(+9.6%)
-$29.24M(-19.0%)
-$100.08M(+3.4%)
Sep 2002
-
-$24.58M(-8.4%)
-$103.64M(+3.6%)
Jun 2002
-
-$22.68M(+3.8%)
-$107.55M(+3.1%)
Mar 2002
-
-$23.58M(+28.1%)
-$111.01M(-0.3%)
Dec 2001
-$110.70M(-73.4%)
-$32.80M(-15.1%)
-$110.70M(-15.6%)
Sep 2001
-
-$28.49M(-9.0%)
-$95.73M(-15.1%)
Jun 2001
-
-$26.14M(-12.3%)
-$83.18M(-15.0%)
Mar 2001
-
-$23.27M(-30.5%)
-$72.35M(-13.3%)
Dec 2000
-$63.85M(-108.7%)
-$17.84M(-11.9%)
-$63.85M(-13.8%)
Sep 2000
-
-$15.94M(-4.2%)
-$56.09M(-17.3%)
Jun 2000
-
-$15.30M(-3.6%)
-$47.82M(-22.2%)
Mar 2000
-
-$14.77M(-46.6%)
-$39.12M(-28.1%)
Dec 1999
-$30.59M(-39.1%)
-$10.08M(-31.4%)
-$30.55M(-12.1%)
Sep 1999
-
-$7.67M(-16.2%)
-$27.26M(-7.4%)
Jun 1999
-
-$6.60M(-6.5%)
-$25.39M(-11.5%)
Mar 1999
-
-$6.20M(+8.7%)
-$22.78M(-4.2%)
Dec 1998
-$21.99M(-60.2%)
-$6.79M(-17.1%)
-$21.86M(-12.9%)
Sep 1998
-
-$5.80M(-45.3%)
-$19.37M(-13.7%)
Jun 1998
-
-$3.99M(+24.4%)
-$17.03M(-4.9%)
Mar 1998
-
-$5.28M(-22.7%)
-$16.23M(-18.5%)
Dec 1997
-$13.72M(-19.3%)
-$4.30M(-24.1%)
-$13.69M(-3.8%)
Sep 1997
-
-$3.46M(-8.6%)
-$13.20M(-6.1%)
Jun 1997
-
-$3.19M(-16.2%)
-$12.43M(-1.5%)
Mar 1997
-
-$2.74M(+27.8%)
-$12.24M(-5.6%)
Dec 1996
-$11.50M(-30.7%)
-$3.80M(-40.7%)
-$11.60M(-12.6%)
Sep 1996
-
-$2.70M(+10.0%)
-$10.30M(-7.3%)
Jun 1996
-
-$3.00M(-42.9%)
-$9.60M(-11.6%)
Mar 1996
-
-$2.10M(+16.0%)
-$8.60M(+2.3%)
Dec 1995
-$8.80M(-54.4%)
-$2.50M(-25.0%)
-$8.80M(-1.1%)
Sep 1995
-
-$2.00M(0.0%)
-$8.70M(-11.5%)
Jun 1995
-
-$2.00M(+13.0%)
-$7.80M(-13.0%)
Mar 1995
-
-$2.30M(+4.2%)
-$6.90M(-23.2%)
Dec 1994
-$5.70M
-$2.40M(-118.2%)
-$5.60M(-75.0%)
Sep 1994
-
-$1.10M(0.0%)
-$3.20M(-52.4%)
Jun 1994
-
-$1.10M(-10.0%)
-$2.10M(-110.0%)
Mar 1994
-
-$1.00M
-$1.00M

FAQ

  • What is Nektar Therapeutics annual operating income?
  • What is the all-time high annual operating profit for Nektar Therapeutics?
  • What is Nektar Therapeutics annual operating profit year-on-year change?
  • What is Nektar Therapeutics quarterly operating income?
  • What is the all-time high quarterly operating profit for Nektar Therapeutics?
  • What is Nektar Therapeutics quarterly operating profit year-on-year change?
  • What is Nektar Therapeutics TTM operating income?
  • What is the all-time high TTM operating profit for Nektar Therapeutics?
  • What is Nektar Therapeutics TTM operating profit year-on-year change?

What is Nektar Therapeutics annual operating income?

The current annual operating profit of NKTR is -$129.92M

What is the all-time high annual operating profit for Nektar Therapeutics?

Nektar Therapeutics all-time high annual operating income is $687.93M

What is Nektar Therapeutics annual operating profit year-on-year change?

Over the past year, NKTR annual operating income has changed by +$5.31M (+3.92%)

What is Nektar Therapeutics quarterly operating income?

The current quarterly operating profit of NKTR is -$35.78M

What is the all-time high quarterly operating profit for Nektar Therapeutics?

Nektar Therapeutics all-time high quarterly operating income is $973.60M

What is Nektar Therapeutics quarterly operating profit year-on-year change?

Over the past year, NKTR quarterly operating income has changed by +$702.00K (+1.92%)

What is Nektar Therapeutics TTM operating income?

The current TTM operating profit of NKTR is -$139.13M

What is the all-time high TTM operating profit for Nektar Therapeutics?

Nektar Therapeutics all-time high TTM operating income is $948.29M

What is Nektar Therapeutics TTM operating profit year-on-year change?

Over the past year, NKTR TTM operating income has changed by -$4.03M (-2.98%)
On this page